These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 5450719)
41. Recommends reanalysis of data. Shott S J Am Vet Med Assoc; 1987 Jul; 191(1):4. PubMed ID: 3610776 [No Abstract] [Full Text] [Related]
42. Suprarenal intraarterial infusion of alloxan and streptozotocin during balloon occlusion of the juxtarenal abdominal aorta: a simple technique for inducing diabetes mellitus in canines with reduced mortality. Salis AI; Peterson RG; Stecker MS; Patel NH; Willis LR; Galley P; Eclavea AC; Dreesen RG Acad Radiol; 2001 Jun; 8(6):473-7. PubMed ID: 11394539 [TBL] [Abstract][Full Text] [Related]
43. [Improved means of reproducing alloxan diabetes in dogs]. Bondarenko MF; Azarian GP; Bobkov IuI; Leont'eva GV Probl Endokrinol (Mosk); 1978; 24(6):82-4. PubMed ID: 724679 [No Abstract] [Full Text] [Related]
44. [Chemically induced (streptozotocin-alloxan) diabetes mellitus in dogs]. Liu S; Wang W; Luo XM; Ye B Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):125-8. PubMed ID: 12212196 [TBL] [Abstract][Full Text] [Related]
45. Mortality and renal failure in the streptozocin-alloxan diabetic dog attributed to contamined alloxan preparations. Cutfield R; Albu DS; Chan IF; Moatamed F; Peric-Golia L; Wilson DE Horm Metab Res; 1984 Oct; 16(10):549-50. PubMed ID: 6500490 [No Abstract] [Full Text] [Related]
46. The effect of alloxan upon canine exocrine pancreatic secretion. Tiscornia OM; Janowitz HD; Dreiling DA Am J Gastroenterol; 1968 Apr; 49(4):328-40. PubMed ID: 5650746 [No Abstract] [Full Text] [Related]